Journal News

Saving the bees with proteomics

Elizabeth Stivison
Nov. 10, 2022

You’ve probably heard about the bees dying. About a third of the world’s food depends on pollinators such as bees, wasps, ants and butterflies — and we are losing them.

A researcher collects naturally mite-resistant bees in the wild to bring back to the University of California, Riverside.
Boris Baer
A researcher collects naturally mite-resistant bees in the wild to bring
back to the University of California, Riverside.

Boris Baer, professor for pollinator health at the Center for Integrated Bee Research at the University of California, Riverside, is an expert on this problem, and in a recent paper in the journal Molecular & Cellular Proteomics, he and his team describe how they have used proteomics creatively to help solve the pollinator crisis.

Many factors are hurting pollinators, including climate change, habitat loss and pesticide use. “We are losing all pollinators,” Baer said. “But in the case of the bees, we are aware of it because beekeepers record the losses.”

The U.S. has lost about two-thirds of its bee population since World War II; sometimes we resort to flying bees in from Australia or, as temperatures rise, even putting ice on top of hives so the wax doesn’t melt.

Among the many threats to pollinators is one specific to honeybees: the mite Varroa destructor, which has infested most of the world’s managed bee populations, weakening or killing whole colonies with the disease varroosis. And as if that weren’t bad enough, mites also can act as vectors for other diseases.

In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.
Boris Baer
In hives at the University of California, Riverside, bee species collected in the wild and bees from managed populations are kept side by side to compare how they respond to stress, including the Varroa destructor mite.

“It’s all doom and gloom. Why do we even continue to live on?” Baer said half-jokingly as he described this crisis. But he is, in fact, doing something about it.

In his recent paper, Baer, collaborating with researchers in Ethiopia and China, compared three types of bees: the European honeybee, which is susceptible to the mite and is the honeybee most common in the U.S., and the African and Eastern honeybees (from Ethiopia and China, respectively), which are naturally resistant to the mite.

The researchers used proteomics to study this naturally occurring resistance and to begin identifying what factors may protect bees. They hope that down the line, beekeepers can use this information to breed resistant bees.

This electron microscope image shows a Varroa destructor mite on a honeybee.
USDA/Wikimedia Commons
This electron microscope image shows a Varroa destructor mite on a honeybee.

Baer hypothesized that the immune response of resistant bees might be different from that of susceptible bees. “Bees have immune systems,” he said. “Bees can defend themselves. You just have to have the right bee.”

Using bees of all three types, the lab exposed half of each type to mites and then compared the proteomes in the hemolymph (bee blood), identifying almost 2,000 proteins. As they had hoped, they found variation between those they had exposed to the mites and those they had not. Crucially, they also found variation between the types of bees.

When the researchers sorted through the data, the two resistant bee genotypes showed an enrichment of proteins related to the immune system and detoxification. This supported the team’s hypothesis and could indicate that the resistant bees are mounting a stronger or different immune response to V. destructor, making it harder for the mites to take hold.

Baer’s lab is planning next to figure out what exactly these particular proteins do and possibly set up a breeding program informed by this data. They also hope to study the Africanized bee, a hybrid cross between the susceptible European bee and the protected African bee that also shows resistance.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Elizabeth Stivison

Elizabeth Stivison is a careers columnist for ASBMB Today and an assistant laboratory professor at Middlebury College.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Glow-based assay sheds light on disease-causing mutations
Journal News

Glow-based assay sheds light on disease-causing mutations

Sept. 2, 2025

University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
Journal News

How signals shape DNA via gene regulation

Aug. 19, 2025

A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.

A game changer in cancer kinase target profiling
Journal News

A game changer in cancer kinase target profiling

Aug. 19, 2025

A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.

How scientists identified a new neuromuscular disease
Feature

How scientists identified a new neuromuscular disease

Aug. 14, 2025

NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
Profile

Unraveling cancer’s spaghetti proteins

Aug. 13, 2025

MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Profile

How HCMV hijacks host cells — and beyond

Aug. 12, 2025

Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.